| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts from HSG 2017
|
|
|
2017
|
15 |
1 |
p. 233-269
|
artikel
|
| 2 |
Abstracts from HSG 2017
|
|
|
|
15 |
1 |
p. 233-269
|
artikel
|
| 3 |
Anxiety, Depression, and the Microbiome: A Role for Gut Peptides
|
Lach, Gilliard
|
|
2017
|
15 |
1 |
p. 36-59
|
artikel
|
| 4 |
Anxiety, Depression, and the Microbiome: A Role for Gut Peptides
|
Lach, Gilliard
|
|
|
15 |
1 |
p. 36-59
|
artikel
|
| 5 |
Chronic Fluoxetine Induces Activity Changes in Recovery From Poststroke Anxiety, Depression, and Cognitive Impairment
|
Vahid-Ansari, Faranak
|
|
2017
|
15 |
1 |
p. 200-215
|
artikel
|
| 6 |
Chronic Fluoxetine Induces Activity Changes in Recovery From Poststroke Anxiety, Depression, and Cognitive Impairment
|
Vahid-Ansari, Faranak
|
|
|
15 |
1 |
p. 200-215
|
artikel
|
| 7 |
Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
|
Ziemssen, Tjalf
|
|
2017
|
15 |
1 |
p. 190-199
|
artikel
|
| 8 |
Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
|
Ziemssen, Tjalf
|
|
|
15 |
1 |
p. 190-199
|
artikel
|
| 9 |
Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis
|
Riccio, Paolo
|
|
2017
|
15 |
1 |
p. 75-91
|
artikel
|
| 10 |
Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis
|
Riccio, Paolo
|
|
|
15 |
1 |
p. 75-91
|
artikel
|
| 11 |
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
|
Bruna, Jordi
|
|
2017
|
15 |
1 |
p. 178-189
|
artikel
|
| 12 |
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
|
Bruna, Jordi
|
|
|
15 |
1 |
p. 178-189
|
artikel
|
| 13 |
Endovascular Ischemic Stroke Models in Nonhuman Primates
|
Wu, Di
|
|
2017
|
15 |
1 |
p. 146-155
|
artikel
|
| 14 |
Endovascular Ischemic Stroke Models in Nonhuman Primates
|
Wu, Di
|
|
|
15 |
1 |
p. 146-155
|
artikel
|
| 15 |
Gut Microbiota and the Neuroendocrine System
|
Farzi, Aitak
|
|
2018
|
15 |
1 |
p. 5-22
|
artikel
|
| 16 |
Gut Microbiota and the Neuroendocrine System
|
Farzi, Aitak
|
|
|
15 |
1 |
p. 5-22
|
artikel
|
| 17 |
Gut Microbiota Are Disease-Modifying Factors After Traumatic Spinal Cord Injury
|
Kigerl, Kristina A.
|
|
2017
|
15 |
1 |
p. 60-67
|
artikel
|
| 18 |
Gut Microbiota Are Disease-Modifying Factors After Traumatic Spinal Cord Injury
|
Kigerl, Kristina A.
|
|
|
15 |
1 |
p. 60-67
|
artikel
|
| 19 |
Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
|
Buscarinu, M. C.
|
|
2017
|
15 |
1 |
p. 68-74
|
artikel
|
| 20 |
Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
|
Buscarinu, M.C.
|
|
|
15 |
1 |
p. 68-74
|
artikel
|
| 21 |
iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management
|
Cheng, Shi-Xiang
|
|
2017
|
15 |
1 |
p. 216-232
|
artikel
|
| 22 |
iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management
|
Cheng, Shi-Xiang
|
|
|
15 |
1 |
p. 216-232
|
artikel
|
| 23 |
Microbiome, Immunomodulation, and the Neuronal System
|
Marietta, Eric
|
|
2018
|
15 |
1 |
p. 23-30
|
artikel
|
| 24 |
Microbiome, Immunomodulation, and the Neuronal System
|
Marietta, Eric
|
|
|
15 |
1 |
p. 23-30
|
artikel
|
| 25 |
Microbiota Signaling Pathways that Influence Neurologic Disease
|
Cox, Laura M.
|
|
2018
|
15 |
1 |
p. 135-145
|
artikel
|
| 26 |
Microbiota Signaling Pathways that Influence Neurologic Disease
|
Cox, Laura M.
|
|
|
15 |
1 |
p. 135-145
|
artikel
|
| 27 |
S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life
|
Gao, Jin
|
|
2018
|
15 |
1 |
p. 156-175
|
artikel
|
| 28 |
S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life
|
Gao, Jin
|
|
|
15 |
1 |
p. 156-175
|
artikel
|
| 29 |
Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy
|
Dorsey, Susan G.
|
|
2017
|
15 |
1 |
p. 176-177
|
artikel
|
| 30 |
Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy
|
Dorsey, Susan G.
|
|
|
15 |
1 |
p. 176-177
|
artikel
|
| 31 |
The “Gut Feeling”: Breaking Down the Role of Gut Microbiome in Multiple Sclerosis
|
Freedman, Samantha N.
|
|
2017
|
15 |
1 |
p. 109-125
|
artikel
|
| 32 |
The “Gut Feeling”: Breaking Down the Role of Gut Microbiome in Multiple Sclerosis
|
Freedman, Samantha N.
|
|
|
15 |
1 |
p. 109-125
|
artikel
|
| 33 |
The Gut Microbiome in Neuromyelitis Optica
|
Zamvil, Scott S.
|
|
2017
|
15 |
1 |
p. 92-101
|
artikel
|
| 34 |
The Gut Microbiome in Neuromyelitis Optica
|
Zamvil, Scott S.
|
|
|
15 |
1 |
p. 92-101
|
artikel
|
| 35 |
The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings
|
Tremlett, Helen
|
|
2017
|
15 |
1 |
p. 102-108
|
artikel
|
| 36 |
The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings
|
Tremlett, Helen
|
|
|
15 |
1 |
p. 102-108
|
artikel
|
| 37 |
The Microbiome and Neurologic Disease: Past and Future of a 2-Way Interaction
|
Ochoa-Repáraz, Javier
|
|
2018
|
15 |
1 |
p. 1-4
|
artikel
|
| 38 |
The Microbiome and Neurologic Disease: Past and Future of a 2-Way Interaction
|
Ochoa-Repáraz, Javier
|
|
|
15 |
1 |
p. 1-4
|
artikel
|
| 39 |
The Microbiome–Gut–Behavior Axis: Crosstalk Between the Gut Microbiome and Oligodendrocytes Modulates Behavioral Responses
|
Ntranos, Achilles
|
|
2017
|
15 |
1 |
p. 31-35
|
artikel
|
| 40 |
The Microbiome–Gut–Behavior Axis: Crosstalk Between the Gut Microbiome and Oligodendrocytes Modulates Behavioral Responses
|
Ntranos, Achilles
|
|
|
15 |
1 |
p. 31-35
|
artikel
|
| 41 |
The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the “MS Microbiome”
|
Pröbstel, Anne-Katrin
|
|
2017
|
15 |
1 |
p. 126-134
|
artikel
|
| 42 |
The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the “MS Microbiome”
|
Pröbstel, Anne-Katrin
|
|
|
15 |
1 |
p. 126-134
|
artikel
|
Tijdschrift beschrijving